EUCTR2006-006851-11-IT进行中（未招募）1 期
TILITY IN RM OF GD-BOBPTA VERSUS GD-DTPA IN THE DEFINITION OF THE RESIDUAL OF THE ADENOMA OF THE HYPOPHYSIS. - ND
OSPEDALE S. RAFFAELE0 个研究点目标入组 15 人开始时间: 2007年2月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •PATIENTS AFFECTED BY ADENOMA OF THE HYPOPHYSIS ALREADY UNDERWENT UNDER SURGERY WITH EVIDENCE OF A RESIDUAL OF ADENOMA IDENTIFIED DURING THE CONTROL VISITS.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •PACEMAKERS,VASCULAR METALLIC PROTESIS;CONTRAST DRUG BEFORE 48 HOURS THE ADMINISTRATION OF THE 2 TESTING CONTRAST DRUG;-CONGESTIVE HEART FAILURE CLASS III OR IV ACCORDING TO NYHA;CLAUSTROPHOBIA; IPERSENSIBILITY TO GADOLINIUM OR OTHER METALS; PREGNANCY AND/OR BREAST-FEEDING ETC.
研究者
相似试验
进行中（未招募）
1 期
Intra-individual comparison of Gd-EOB-DTPA disodium (Primovist) and Gadobutrol (Gadovist) in patients with suspicion of hepatocellular carcinoma - Primovist® in HCCPatients of both genders are eligible for this study in case they present with suspicion of HCC after Gadovist® -enhanced MRI.MedDRA version: 12.0Level: LLTClassification code 10036706Term: Primary liver cancer non-resectableMedDRA version: 12.0Level: LLTClassification code 10036707Term: Primary liver cancer recurrentMedDRA version: 12.0Level: LLTClassification code 10036708Term: Primary liver cancer resectableEUCTR2009-011095-30-DEMedizinische Fakultät Mannheim, Ruprecht-Karls-Universität Heidelberg42
已完成
2 期
TREATMENT OF ISOLATED GINGIVAL RECESSION BY GINGIVAL PEDICLE SPLIT THICKNESS TUNNEL TECHNIQUE WITH AND WITHOUT USING I-PRF.CTRI/2021/11/037987EENA PATI20
进行中（未招募）
1 期
COMPARE STEMI ONE- Comparison Of reduced DAPT followed by P2Y12 inhibitor Monotherapy with Prasugrel vs stAndard Regimen in STEMI patients treated with OCT-guided vs aNgio-guided completE revascularization.ST elevated myocard infarction followed by PCIEUCTR2021-005499-20-NLResearch Maatschap Cardiologen Rotterdam Zuid1,656
进行中（未招募）
1 期
COMPARE STEMI ONE- Comparison Of reduced DAPT followed by P2Y12 inhibitor Monotherapy with Prasugrel vs stAndard Regimen in STEMI patients treated with OCT-guided vs aNgio-guided completE revascularization.St-Elevated Myocardial InfartionCTIS2024-515883-30-00Research Maatschap Cardiologen Rotterdam Zuid1,200
招募中
1 期
COMPARE STEMI ONE- Comparison Of reduced DAPT followed by P2Y12 inhibitor Monotherapy with Prasugrel vs stAndard Regimen in STEMI patients treated with OCT-guided vs aNgio-guided completE revascularization.EUCTR2021-005499-20-DEResearch Maatschap Cardiologen Rotterdam Zuid1,656